Business Wire

CO-VANTAGE-DATA-CENTERS

24.4.2024 12:01:33 CEST | Business Wire | Press release

Share
Vantage Data Centers Expands EMEA Portfolio with First Dublin Campus Featuring Next-Generation Energy Solution

Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced its entrance into the Irish market with the development of a multi-phase data center campus (DUB1). The company will invest more than €1 billion over multiple phases to support the construction and delivery of the campus in one of the largest data center markets in Europe. The first two phases consist of 52MW of IT capacity, with the first phase expected to be operational in late 2024. Upon completion, DUB1 will mark Vantage’s 14th EMEA campus in a growing regional portfolio that spans seven countries.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424930079/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Vantage Data Centers’ flagship Dublin campus will include 52MW of IT capacity to enable next-generation applications and digital transformation. (Graphic: Business Wire)

The company’s flagship Ireland campus will be located approximately nine miles (15 kilometers) from the Dublin City Center in Profile Park, Grange Castle, an area known for its data centers. Sited on 22 acres (nine hectares), the 405,000 square foot (38,000 square meter) campus will consist of one 32MW facility and one 20MW facility and has available land and power to add a third facility in the future. The highly efficient campus is being built in alignment with Vantage’s sustainable blueprint to deliver an industry-leading annualized Power Usage Effectiveness (PUE) of 1.2 using virtually no water for cooling.

Vantage Data Centers is committed to achieving net zero carbon emissions by 2030 and drives emission reductions through the use of renewable energy and sustainable fuel alternatives across its value chain. This aligns with Ireland’s climate action plans and with the environmental commitments of the company’s key customers.

The DUB1 campus will include an on-site 100MVA multi-fuel generation plant capable of running a combination of fuels, primarily hydrotreated vegetable oil (HVO), a renewable fuel, and gas fed by Gas Networks Ireland. Given the temporary power constraints in Dublin, this on-site generation plant will support current capacity constraints by alleviating pressure on energy demand from the grid while achieving optimal efficiency and power output. The generation plant is also capable of funneling power back to the grid, further supporting power availability in the Dublin area. In addition, Vantage plans to deploy HVO in place of conventional diesel fuel throughout its fleet of back-up generators and is working to obtain corporate power purchase agreements (CPPAs) for green energy, such as biomethane from local providers. Currently, the company is leveraging HVO for 99% of its fuel requirements during the construction phase.

“The South Dublin Chamber warmly welcomes the confidence shown in our area through the €1 billion investment by Vantage Data Centers,” said Peter Byrne, CEO, South Dublin Chamber. “Vantage Data Centers will not only be contributing to local employment and taxation but will be ensuring the safety of our data and future-proofing business for years to come with this major investment in technology.”

“With Dublin being one of the biggest data center markets in the world, this expansion further solidifies Vantage’s role at the forefront of the digital infrastructure revolution and signifies the start of a strong partnership with local officials and the community,” said David Howson, president, EMEA at Vantage Data Centers. “Throughout this development, there will be a significant positive economic impact to the community as we employ more than 1,100 individuals during peak construction and create approximately 165 jobs to operate the campus. Vantage is committed to being a good neighbor where we build and operate data centers, and we are eager to continue working with community organizations such as Round Tower GAA Club, Newcastle Tidy Towns, St. Francis Football Club, Ballyboden St. Enda’s GAA, St. Ronan’s National School in Deansrath and others.”

“Vantage is committed to environmental responsibility and is pleased that our sustainability goals, including reducing emissions, achieving net zero carbon emissions by 2030 and maximizing energy efficiency, align closely with those of the Irish government and regulatory bodies as we continue growing Ireland’s position as a leader in the digital age for cloud computing,” said Jinél Fourie, director of public policy, EMEA at Vantage Data Centers. “As environmental technology continues to advance, including the inaugural use of a multi-fuel generation plant in Dublin, we look forward to continuing our local partnerships to explore additional solutions to enhance the local community.”

For more information on Vantage Data Centers’ campuses, please visit: https://vantage-dc.com/data-center-locations/.

About Vantage Data Centers

Vantage Data Centers powers, cools, protects and connects the technology of the world’s well-known hyperscalers, cloud providers and large enterprises. Developing and operating across five continents in North America, EMEA and Asia Pacific, Vantage has evolved data center design in innovative ways to deliver dramatic gains in reliability, efficiency and sustainability in flexible environments that can scale as quickly as the market demands.

For more information, visit www.vantage-dc.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240424930079/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release

In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release

IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye